Cargando…

Variation in suspected cancer referral pathways in primary care: comparative analysis across the International Benchmarking Cancer Partnership

BACKGROUND: International variations in cancer outcomes persist and may be influenced by differences in the accessibility and organisation of cancer patient pathways. More evidence is needed to understand to what extent variations in the structure of primary care referral pathways for cancer investi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lynch, Charlotte, Harrison, Samantha, Emery, Jon D, Clelland, Cathy, Dorman, Laurence, Collins, Claire, Johansen, May-Lill, Lawrenson, Ross, Surgey, Alun, Weller, David, Jarbøl, Dorte Ejg, Balasubramaniam, Kirubakaran, Nicholson, Brian D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal College of General Practitioners 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512411/
https://www.ncbi.nlm.nih.gov/pubmed/36127155
http://dx.doi.org/10.3399/BJGP.2022.0110
_version_ 1784797838592442368
author Lynch, Charlotte
Harrison, Samantha
Emery, Jon D
Clelland, Cathy
Dorman, Laurence
Collins, Claire
Johansen, May-Lill
Lawrenson, Ross
Surgey, Alun
Weller, David
Jarbøl, Dorte Ejg
Balasubramaniam, Kirubakaran
Nicholson, Brian D
author_facet Lynch, Charlotte
Harrison, Samantha
Emery, Jon D
Clelland, Cathy
Dorman, Laurence
Collins, Claire
Johansen, May-Lill
Lawrenson, Ross
Surgey, Alun
Weller, David
Jarbøl, Dorte Ejg
Balasubramaniam, Kirubakaran
Nicholson, Brian D
author_sort Lynch, Charlotte
collection PubMed
description BACKGROUND: International variations in cancer outcomes persist and may be influenced by differences in the accessibility and organisation of cancer patient pathways. More evidence is needed to understand to what extent variations in the structure of primary care referral pathways for cancer investigation contribute to differences in the timeliness of diagnoses and cancer outcomes in different countries. AIM: To explore the variation in primary care referral pathways for the management of suspected cancer across different countries. DESIGN AND SETTING: Descriptive comparative analysis using mixed methods across the International Cancer Benchmarking Partnership (ICBP) countries. METHOD: Schematics of primary care referral pathways were developed across 10 ICBP jurisdictions. The schematics were initially developed using the Aarhus statement (a resource providing greater insight and precision into early cancer diagnosis research) and were further supplemented with expert insights through consulting leading experts in primary care and cancer, existing ICBP data, a focused review of existing evidence on the management of suspected cancer, published primary care cancer guidelines, and evaluations of referral tools and initiatives in primary care. RESULTS: Referral pathway schematics for 10 ICBP jurisdictions were presented alongside a descriptive comparison of the organisation of primary care management of suspected cancer. Several key areas of variation across countries were identified: inflexibility of referral pathways, lack of a managed route for non-specific symptoms, primary care practitioner decision-making autonomy, direct access to investigations, and use of emergency routes. CONCLUSION: Analysing the differences in referral processes can prompt further research to better understand the impact of variation on the timeliness of diagnoses and cancer outcomes. Studying these schematics in local contexts may help to identify opportunities to improve care and facilitate discussions on what may constitute best referral practice.
format Online
Article
Text
id pubmed-9512411
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Royal College of General Practitioners
record_format MEDLINE/PubMed
spelling pubmed-95124112022-10-21 Variation in suspected cancer referral pathways in primary care: comparative analysis across the International Benchmarking Cancer Partnership Lynch, Charlotte Harrison, Samantha Emery, Jon D Clelland, Cathy Dorman, Laurence Collins, Claire Johansen, May-Lill Lawrenson, Ross Surgey, Alun Weller, David Jarbøl, Dorte Ejg Balasubramaniam, Kirubakaran Nicholson, Brian D Br J Gen Pract Research BACKGROUND: International variations in cancer outcomes persist and may be influenced by differences in the accessibility and organisation of cancer patient pathways. More evidence is needed to understand to what extent variations in the structure of primary care referral pathways for cancer investigation contribute to differences in the timeliness of diagnoses and cancer outcomes in different countries. AIM: To explore the variation in primary care referral pathways for the management of suspected cancer across different countries. DESIGN AND SETTING: Descriptive comparative analysis using mixed methods across the International Cancer Benchmarking Partnership (ICBP) countries. METHOD: Schematics of primary care referral pathways were developed across 10 ICBP jurisdictions. The schematics were initially developed using the Aarhus statement (a resource providing greater insight and precision into early cancer diagnosis research) and were further supplemented with expert insights through consulting leading experts in primary care and cancer, existing ICBP data, a focused review of existing evidence on the management of suspected cancer, published primary care cancer guidelines, and evaluations of referral tools and initiatives in primary care. RESULTS: Referral pathway schematics for 10 ICBP jurisdictions were presented alongside a descriptive comparison of the organisation of primary care management of suspected cancer. Several key areas of variation across countries were identified: inflexibility of referral pathways, lack of a managed route for non-specific symptoms, primary care practitioner decision-making autonomy, direct access to investigations, and use of emergency routes. CONCLUSION: Analysing the differences in referral processes can prompt further research to better understand the impact of variation on the timeliness of diagnoses and cancer outcomes. Studying these schematics in local contexts may help to identify opportunities to improve care and facilitate discussions on what may constitute best referral practice. Royal College of General Practitioners 2022-09-21 /pmc/articles/PMC9512411/ /pubmed/36127155 http://dx.doi.org/10.3399/BJGP.2022.0110 Text en © The Authors https://creativecommons.org/licenses/by/4.0/This article is Open Access: CC BY 4.0 licence (http://creativecommons.org/licences/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ).
spellingShingle Research
Lynch, Charlotte
Harrison, Samantha
Emery, Jon D
Clelland, Cathy
Dorman, Laurence
Collins, Claire
Johansen, May-Lill
Lawrenson, Ross
Surgey, Alun
Weller, David
Jarbøl, Dorte Ejg
Balasubramaniam, Kirubakaran
Nicholson, Brian D
Variation in suspected cancer referral pathways in primary care: comparative analysis across the International Benchmarking Cancer Partnership
title Variation in suspected cancer referral pathways in primary care: comparative analysis across the International Benchmarking Cancer Partnership
title_full Variation in suspected cancer referral pathways in primary care: comparative analysis across the International Benchmarking Cancer Partnership
title_fullStr Variation in suspected cancer referral pathways in primary care: comparative analysis across the International Benchmarking Cancer Partnership
title_full_unstemmed Variation in suspected cancer referral pathways in primary care: comparative analysis across the International Benchmarking Cancer Partnership
title_short Variation in suspected cancer referral pathways in primary care: comparative analysis across the International Benchmarking Cancer Partnership
title_sort variation in suspected cancer referral pathways in primary care: comparative analysis across the international benchmarking cancer partnership
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512411/
https://www.ncbi.nlm.nih.gov/pubmed/36127155
http://dx.doi.org/10.3399/BJGP.2022.0110
work_keys_str_mv AT lynchcharlotte variationinsuspectedcancerreferralpathwaysinprimarycarecomparativeanalysisacrosstheinternationalbenchmarkingcancerpartnership
AT harrisonsamantha variationinsuspectedcancerreferralpathwaysinprimarycarecomparativeanalysisacrosstheinternationalbenchmarkingcancerpartnership
AT emeryjond variationinsuspectedcancerreferralpathwaysinprimarycarecomparativeanalysisacrosstheinternationalbenchmarkingcancerpartnership
AT clellandcathy variationinsuspectedcancerreferralpathwaysinprimarycarecomparativeanalysisacrosstheinternationalbenchmarkingcancerpartnership
AT dormanlaurence variationinsuspectedcancerreferralpathwaysinprimarycarecomparativeanalysisacrosstheinternationalbenchmarkingcancerpartnership
AT collinsclaire variationinsuspectedcancerreferralpathwaysinprimarycarecomparativeanalysisacrosstheinternationalbenchmarkingcancerpartnership
AT johansenmaylill variationinsuspectedcancerreferralpathwaysinprimarycarecomparativeanalysisacrosstheinternationalbenchmarkingcancerpartnership
AT lawrensonross variationinsuspectedcancerreferralpathwaysinprimarycarecomparativeanalysisacrosstheinternationalbenchmarkingcancerpartnership
AT surgeyalun variationinsuspectedcancerreferralpathwaysinprimarycarecomparativeanalysisacrosstheinternationalbenchmarkingcancerpartnership
AT wellerdavid variationinsuspectedcancerreferralpathwaysinprimarycarecomparativeanalysisacrosstheinternationalbenchmarkingcancerpartnership
AT jarbøldorteejg variationinsuspectedcancerreferralpathwaysinprimarycarecomparativeanalysisacrosstheinternationalbenchmarkingcancerpartnership
AT balasubramaniamkirubakaran variationinsuspectedcancerreferralpathwaysinprimarycarecomparativeanalysisacrosstheinternationalbenchmarkingcancerpartnership
AT nicholsonbriand variationinsuspectedcancerreferralpathwaysinprimarycarecomparativeanalysisacrosstheinternationalbenchmarkingcancerpartnership